Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
Clinical trial NCT01324947 · COMPLETED
Trial details
- NCT number
- NCT01324947
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-07-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.